News Sentiment

TGTX sentiment intelligence

TG Therapeutics Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 57 Balanced news tone 56 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 57.12 Week of 10 Jul 2026
Weighted tone 57/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

79/100 classification confidence.

Company focus 47

directly relevant articles

Source quality 0

high-authority source matches

Trend context Trend active

+7.1% over one week, +15.3% over four weeks, trend active, and materially above fair value.

Latest direct headline Negative

Law firm investigates TG Therapeutics officers for possible self-dealing harming shareholders

Market Reaction

Price moving ahead of tone

66/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Market update 79/100 classification
One-week reaction 7.1% Price confirming higher
Trend fit Trend active 15.3% over four weeks
Fair value 114.0% Materially above fair value

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 20
Neutral 31
Negative 5

Relevance

Why the article matched

Direct first
Direct company coverage 47
Industry context 9
Sector context 0

Sources

Coverage mix

Publishers
Market source 17
TradingView 9
simplywall.st 5
Simply Wall Street 3
The Globe and Mail 3
Stock Titan 3
Stocktwits 2
Insider Monkey 2

Event Lens

What the news is about

Classified themes
Market update 29
Earnings 18
Analyst action 5
Balance sheet 2
Regulatory and legal 1
Capital return 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 31-56 of 56
Stock Traders Daily Direct company coverage

Responsive Playbooks and the TGTX Inflection

This article provides an in-depth analysis of Tg Therapeutics Inc. (NASDAQ: TGTX) based on AI models from Stock Traders Daily. It highlights strong near and mid-term sentiment, compelling upside potential due to no resistance levels above current price, and offers three distinct

Tone
Positive 76/100
Event
Market update
Published
29 Jun 2026 06:48
Source
Stock Traders Daily
TradingView Direct company coverage

Price to earnings forward of TG Therapeutics, Inc. – NASDAQ:TGTX

This article displays the "Price to earnings forward" metric for TG Therapeutics, Inc. (NASDAQ: TGTX). It indicates the value and change percentage for a specified period and is presented within the context of TradingView's financial data. The information is sourced from ICE Data

Tone
Neutral 50/100
Event
Earnings
Published
26 Jun 2026 18:39
Source
TradingView
TradingView Direct company coverage

Enterprise value to EBITDA forward of TG Therapeutics, Inc. – FWB:NKB2

The article provides financial information for TG Therapeutics, Inc. (NKB2) on the Frankfurt Stock Exchange, specifically focusing on its enterprise value to EBITDA forward. It indicates that the market was closed with no trades recorded at the time of publication. The content al

Tone
Neutral 50/100
Event
Market update
Published
26 Jun 2026 03:09
Source
TradingView
TradingView Direct company coverage

Enterprise value to EBIT forward of TG Therapeutics, Inc. – NASDAQ:TGTX

The article discusses the enterprise value to EBIT forward of TG Therapeutics, Inc. (NASDAQ: TGTX). It presents a financial metric within the context of the company's profile on TradingView, which provides market data and financial tools. The content primarily focuses on the disp

Tone
Neutral 50/100
Event
Market update
Published
26 Jun 2026 01:09
Source
TradingView
Simply Wall Street Direct company coverage

TG Therapeutics (TGTX) Gains Momentum As The Fair Value Narrative Turns More Cautious

TG Therapeutics (TGTX) has seen significant share price gains recently, prompting a re-evaluation of its valuation. While the most followed narrative suggests the stock is currently 4% overvalued at $51.71, Simply Wall St's DCF model indicates a fair value of $207.76, suggesting

Tone
Positive 64/100
Event
Market update
Published
25 Jun 2026 19:09
Source
Simply Wall Street
TradingView Direct company coverage

TGTX Forecast — Price Target — Prediction for 2027

This article provides a forecast and price target for TG Therapeutics, Inc. (TGTX) stock, based on analyst opinions and recent financial performance. It includes current stock price, historical data, earnings reports, revenue figures, and market capitalization, along with frequen

Tone
Positive 70/100
Event
Earnings
Published
25 Jun 2026 15:09
Source
TradingView